Part 4- Real world experience with Acalabrutinib in management Treatment naïve CLL- Dr. John M Pagel Published 2020-10-12 Download video MP4 360p Download video MP4 720p Recommendations 35:19 Part 6 - Panel Discussion - Dr Chezian Subhash, Chennai 04:18 Treatment Options for Chronic Lymphocytic Leukemia (CLL) 02:57 Selecting between ibrutinib, acalabrutinib and zanubrutinib in the frontline setting in CLL 2:13:17 An Evening with Strain 2:29:54 #162 - Sarah Hallberg, D.O., M.S.: Treating metabolic disease, & a personal journey through cancer 1:02:33 Non-Hodgkin Lymphoma Stories: Stage 4 Survivor Shares Her Entire Treatment Journey | Mags' Story 19:51 Cancer Survivor Story: Non-Hodgkin Lymphoma | The Patient Story 1:24:17 Hyperbaric Oxygen Therapy | Dr. Susan Sprau - UCLA Health 58:05 Introduction to Medical Cannabis by Dr. Stacy D'Andre 55:10 CAR-T Cell Therapy: Now and in 2030 | Laboratory Medicine and Pathology in Individualized Medicine 3:29:21 Dr. Robert Lustig: How Sugar & Processed Foods Impact Your Health 58:43 Multiple Sclerosis in 2022 2:37:15 Dr. Matthew Walker on Sleep for Enhancing Learning, Creativity, Immunity, and Glymphatic System 03:11 BTK inhibitors for CLL: acalabrutinib vs ibrutinib 1:30:49 Colon Cancer Survivor: "I Didn't Think I Had Symptoms, Diagnosed Stage 3B" | Shelley's Story 1:28:26 Cancer Metabolism: From molecules to medicine 3:46:40 273 ‒ Prostate health: common problems, cancer prevention, screening, treatment, and more 1:47:16 Untangling Dementia: Tam Cummings, PhD Gerontologist 09:42 Mayo Clinic: William Palmer, M.D. - Hereditary Hemochromatosis 44:24 Basics of EP Testing and Ablation by Adam Zivin, M.D. Similar videos 31:15 CALQUENCE® (acalabrutinib) Clinical Insights from a Real-World Patient with Treatment Naive CLL 21:57 Part 5 - Clinical World Experience with Acalabrutinib in management of R/R CLL - Prof. Paolo Ghia 2:51:48 Shifting treatment paradigm in management of Chronic Lymphocytic Leukemia 2:04:18 Living with Chronic Lymphocytic Leukemia (CLL): A CALQUENCE™ Connections Virtual Event 1:02:15 Not Your Father's CLL with Dr. John Pagel 38:13 Part 3 - Expert guidance on management of CLL patients with Acalabrutinib - Prof. Peter Hillmen, UK 03:20 Matching-adjusted indirect comparisons of acalabrutinib vs ibrutinib in treatment-naïve CLL 03:16 ELEVATE-TN: approval of acalabrutinib for adult CLL 02:36 ELEVATE CLL TN & ASCEND: acalabrutinib in CLL 35:31 CLL: BTK Inhibitors in Hematologic Oncology Pathways - Pathway-Guided Choices 02:52 First results of head-to-head acalabrutinib versus ibrutinib in CLL 01:24 5-year update of ELEVATE CLL TN 01:46 Acalabrutinib for the treatment of Richter's transformation and patients with ibrutinib intolerance 03:10 ASCEND: acalabrutinib in R/R CLL 04:11 CLL: Practical Advice on Selecting and Managing Therapy 01:08 Overview of the Phase I study with acalabrutinib (ACP-196) in CLL 00:50 Dr. Furman on Acalabrutinib Monotherapy in CLL 04:55 First results of a head-to-head trial of acalabrutinib versus ibrutinib in previously treated ch... More results